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AbStrAct
Thirty nine escherichia coli (e. coli) isolated from septicaemic clinical cases between October 2005 
and March 2006 from eleven poultry farms in Abeokuta, South West Nigeria were tested for their in vitro 
antimicrobial drug sensitivity pattern. The e. coli were isolated from two hundred and fifty samples comprising 
of intestine, kidneys, lungs, hearts, ovary, spleen and colo-rectum from diseased chickens (mostly commercial 
layers) submitted for post-mortem examination. Eight of the poultry farms studied disclosed that they had 
used between 3 to 7 different antimicrobial agents either for treatment, prophylaxis or as growth promoters 
within the studied period. The result indicated that the 39 e. coli isolates showed nineteen different multidrug-
resistant patterns to Nitrofurantoin (100 µg), Cefuroxime (20 µg), Norfloxacin (10 µg), Cotrimoxazole (50 µg), 
Ciprofloxacin (5 µg), Nalidicic acid (30 µg), Chloramphenicol (10 µg), Ampicillin (10 µg, 25 µg), Ofloxacin (5 
µg), Penicillin G (5 i.u), Amoxylin (20 µg), and Cloxacilin (5 µg, 10 µg) discs that were tested.
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introduction
e. coli is one of the most common causes of infection by gram negative bacteria 
(DIEKEMA et al., 1999). Although drug resistance in gram negative bacteria is not 
uncommon, its occurrence among isolates of e. coli was considered unusual (MUDER 
et al., 1997; VROMEN et al., 1999). Furthermore, there are more data on the prevalence of 
antimicrobial resistance among gram positive organism especially methicilin resistant 
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staphylococcus aureus and vancomycin resistant enterococcus faecalis and enterococcus 
faecium than there are for gram negative bacteria (FEINGOLD et al., 1994; BONILLA et al., 
1997). Nevertheless, there are reports of resistance of e. coli to antibiotics with associated 
treatment failure (TALAN et al., 2004; BLONDAEU, 2004). Included in the list of affected 
antimicrobials are penicillin, cephalosporin, sulpha drugs (FLUTT et al., 2000; SAHM et al., 
2001) and fluoroquinolones (GOETTSCH et al., 2000).
Fluoroquinolone resistant e. coli strains often show resistance to other drugs such 
as ampicilin, tetracycline, chloramphenicol, trimethoprin, sulphamethoxazole and 
Gentamycin (GARAU et al., 1999; KOMP et al., 2003). And there has been a significant 
increase in fluoroquinolones resistant e. coli in many countries over the last few decades 
(GARAU et al., 1999; VAN BELKUM et al., 2001; VIROY et al., 2005).
There is growing concern over the transmission of resistant bacteria through the food 
chain and to that effect, the W.H.O. has recognised that antibiotic use in animals affects 
antibiotic resistance in human (ANONYMOUS, 2000). In the current study we studied 
the antimicrobial resistant pattern of e. coli isolated from eleven poultry farms, eight of 
which were known to have a history of multiple antimicrobial usage for both prophylaxis 
and therapeutic purposes in Ogun State, Nigeria.
Materials and methods
sample collection. The study was carried out between October 2005 and March 2006 
in eleven poultry farms comprising one breeding farm and ten commercial laying hen 
farms. Eight of the farms had a history of previous usage of various antibiotics, either 
for therapy or prophylaxis in Abeokuta, Ogun State. Carcasses from birds that had died 
of suspected septicaemic clinical cases were collected and aseptic specimens of liver, 
intestine, kidneys, lungs, heart, ovary, spleen and colorectum, totalling two hundred and 
fifty samples, were obtained from the series over the stated period. The specimens were 
immediately transported to the laboratory for bacteriological investigation.
Bacteriological analysis. The samples were streaked onto 5% sheep blood agar 
and MacConkey agar and incubated aerobically at 37 oC for 24 - 48 hours. All isolates 
that fermented lactose within 24 - 48 hours on MacConkey agar were further identified 
morphologically and biochemically according to standard methods (BARROW and 
FELTHAM, 1993). The in vitro antimicrobial sensitivity for the e. coli isolates was 
carried out by the agar - disc diffusion test (MATSEN and BARRY, 1974) using discs of 
Nitrofurantoin (NIT) 100 µg, Cefuroxine (CEF), 20 µg, Norfloxacin (NOR), 10 µg, 
Cotrimoxazole (COR), 50 µg, Nalidicic acid (NAL), 30 µg, Chloramphenicol (CHL) 10 
µg, Ampicilin (AMP) 25 µg, Ofloxacin (OFL), 5 µg, Penincilin G (PEN) 5 unit, Amoxylin 
(AMX), 20 µg, Cloxacillin (CXC), 5 µg, Cefuroxine (CEF), 30 µg, Ampicillin (AMP) 10 
µg,,using oxoid iso-sensitest agar.
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results
From the two hundred and fifty samples that were examined, a total of thirty nine 
e. coli isolates were obtained. Each of the thirty nine isolates was resistant to between 5 
and 12 antimicrobial agents. These isolates were from various organs: liver 26/39 (67%), 
lungs 4/39 (10%), kidneys 1/39 (2.5%), ovary 1/39 (2.5%), colorectum 2/39 (5%), and 
intestine 4/39 (10%). Table 1 shows the pattern of antimicrobial resistance exhibited by 
the e. coli isolates. Table 2 shows the history of antibiotic usage in the poultry farms used 
for the study and Table 3 shows the relationship between the antimicrobial resistance 
pattern obtained with the antimicrobials previously used in the respective farms.
Table 1. Antimicrobial disc resistant pattern exhibited by the escherichia coli isolated from 
different farms
Multidrug resistant pattern Frequency Farm sources
1 R-CIP-NOR-OFL-NIT-TET-PEN-AMX-CXC-CHL-CEF-AMP-GEN 3 1,2
2 R-CIP-NOR-NIT-TET-CHL-CEF-AMP-COR-GEN-NAL 3 1,2
3 R-CIP-NOR-NIT-TET-CHL-CEF-AMP-GEN-OFL-AMX 11 1,11
4 R-CXC-NIT-PEN-NOR-CHL-GEN 1 3
5 R-TET-NOR-NIT-COR-AMP-CHL-NAL 3 4,5
6 R-NOR-NIT-TET-CEF-COR-AMP-GEN-NAL 3 10
7 R-PEN-NIT-CEF-COR-CHL 1 1
8 R-NOR-NIT-TET-PEN-CXC-CEF-AMP-GEN-COR-NAL 1 1
9 R-CIP-NOR-NIT-TET-PEN-CXC-CEF-COR-AMP-NAL 1 1
10 R-CXC-NIT-PEN-CEF-AMP 1 1
11 R-NIT-CEF-TET-AMP-NAL 1 6
12 R-CXC-NIT-PEN-TET-CEF-AMP 1 6
13 R-NIT-CEF-TET-NOR-COR-CHL-AMP-NAL 1 5
14 R-NOR-COR-CEF-TET-AMP-NAL 1 9
15 R-NOR-COR-CEF-NIT-AMP-GEN-PEN-NAL 1 9
16 R-NOR-COR-CEF-AMP-GEN-TET-NAL 1 9
17 R-CIP-NIT-COR-CEF-TET-AMP-CHL-GEN-NAL 2 7
18 R-CIP-CEF-NOR-TET-AMP-CHL-GEN-OFL 2 7
19 R-CIP-CEF-NOR-TET-AMP-GEN-OFL 1 7
Total 39 11
R- Resistant, NIT- Nitrofurantoin, CEF- Cefuroxine, NOR- Norfloxacin, COR- Cotrimoxazole, GEN-
Gentamyncin, TET- Tetracycline, CIP- Ciprofloxacin, NAL- Nalidicic acid, CHL- Chloramphenicol, AMP- 
Ampicillin, OFL- Ofloxacin, PEN- Penincillin, AMX- Amoxylin, CXC- Cloxacillin
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Table 2. History of previous antimicrobial drug usage in the farms
S/N Farm studied Previous antimicrobial drug
1 1 Enrofloxacin, Tetracycline (four time), Gentamycin injectable (twice), Streptomycin injectable (twice)
2 2 Enrofloxacin, Furatadone, Gentamycin, Norfloxacin
3 3 Enrofloxacin (Twice), Gentamycin (Twice), Tetracycline (Three times), Furatadone (Twice), Streptomycin
4 4 Tetracycline only
5 5 Oxytetratcycline, Tylosine, Enrofloxacin, Gentamycin injectable (280 mg) Furatadone
6 6 Not available 
7 7 Not available
8 8 Oxytetracycline, 20%, Norfloxacin, Gentamycin, Streptomycin injectable
9 9 Gentamycin injectable (three times), Tetracycline, Enrofloxacin (three times), 
Norfloxacin, Furatadone (twice), Furazolidone (three times) injectable
10 10 Gentamycin (three time) injectable, Enrofloxacin (twice), Oxytetracycline 20% injectable
11 11 Not available
Table 3. Comparison of antimicrobial resistance pattern with the antimicrobial agents previously 
used in the respective farms





1 R-CIP-NOR-OFL-NIT-TET-PEN-AMX-CXC-CHL-CEF-AMP-GEN 3 1, 2
D-CIP-GEN-TET-
NOR
2 R-CIP-NOR-NIT-TET-CHL-CEF-AMP-COR-GEN-NAL 3 1,2
D-CIP-GEN-TET-
NOR
3 R-CIP-NOR-NIT-TET-CHL-CEF-AMP-GEN-OFL-AMX 11 1, 11
D-CIP-GEN-TET-
NOR
4 R-CXC-NIT-PEN-NOR-CHL-GEN 1 3 D-CIP-GEN-TET-STEP
5 R-TET-NOR-NIT-COR-AMP-CHL-NAL 3 4, 5 D-CIP-GEN-TET-NOR
6 R-NOR-NIT-TET-CEF-COR-AMP-GEN-NAL 3 10 D-CIP-GEN-TET-NOR
7 R-PEN-NIT-CEF-COR-CHL 1 1 D-CIP-GEN-TET-NOR
8 R-NOR-NIT-TET-PEN-CXC-CEF-AMP-GEN-COR-NAL 1 1
D-CIP-GEN-TET-
NOR
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9 R-CIP-NOR-NIT-TET-PEN-CXC-CEF-COR-AMP-NAL 1 1
D-CIP-GEN-TET-
NOR
10 R-CXC-NIT-PEN-CEF-AMP 1 1 D-CIP-GEN-TET-NOR
11 R-NIT-CEF-TET-AMP-NAL 1 6 Not available
12 R-CXC-NIT-PEN-TET-CEF-AMP 1 6 Not available
13 R-NIT-CEF-TET-NOR-COR-CHL-AMP-NAL 1 5 D-CIP-GEN-TET-NOR
14 R-NOR-COR-CEF-TET-AMP-NAL 1 9 D-CIP-GEN-TET-NOR
15 R-NOR-COR-CEF-NIT-AMP-GEN-PEN-NAL 1 9 D-CIP-GEN-TET-NOR
16 R-NOR-COR-CEF-AMP-GEN-TET-NAL 1 9 D-CIP-GEN-TET-NOR
17 R-CIP-NIT-COR-CEF-TET-AMP-CHL-GEN-NAL 2 7 Not available
18 R-CIP-CEF-NOR-TET-AMP-CHL-GEN-OFL 2 7 Not available
19 R-CIP-CEF-NOR-TET-AMP-GEN-OFL 1 7 Not available
Total 39 11
D - Drug previously used
Discussion
Antimicrobial resistance has grown to become a global problem (GUNNER et al., 
2004). Antibiotic usage, that is, inappropriate use in terms of over use and misuse both in 
humans, veterinary use and agriculture is considered the most important factor promoting 
the emergence, selection and dissemination of antibiotic resistant micro organisms in 
both veterinary and human medicine (NEU, 1992; WITTE. 1998; GUNNER et al., 2004). 
Large proportions of antibiotics (50%) of the total global consumption are administered 
to food producing animals for prophylaxis treatment and growth promotion purposes, but 
80% of such total administration is unnecessary (HARRISON and LEDERBERG, 1998).
The practice of indiscriminate use of antibiotics in food producing animals has 
undesirable consequences on human health because of the presence of drug residue 
in foods (which may be the parent compound or compounds derived from the parent 
drugs or both, including metabolites and residue bound to macromolecules on the one 
hand and the selection of resistant bacteria in animals on the other), thus jeopardizing 
Table 3. Comparison of antimicrobial resistance pattern with the antimicrobial agents previously 
used in the respective farms (continued)
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the effectiveness of the treatment of bacterial, fungal and parasitic infections worldwide 
(WEBER, 1979; COSGROVE and CARMEH, 2003).
This study presents a good example of typical use of antimicrobial agents by most 
poultry farmers in Nigeria and the possible consequences of such practices. Table 2 shows 
the disclosed history of antimicrobial usage in the farms studied (a very difficult task to 
accomplish because of reluctance on the part of the farmers to release the information). 
Seven of the eight farms with disclosed history used between three to seven different 
antimicrobial agents at different times, either for prophylaxis, treatment or growth 
promoting purposes. One farm (farm four) disclosed a history of tetracycline usage only. 
Three farms did not disclose antibiotic usage at all. However, the detailed dose/dosages 
of administration of the antibiotics and the duration of the therapy were not disclosed. 
The inability to access the antimicrobial usage record on demand is a reflection of bad 
management practice, because it makes it difficult to consider the justification for the use 
of such antimicrobial agents.
However, all the farms with a history of antimicrobial usage used at least one of 
quinolones (enrofloxacin, ciprofloxacin, norfloxacin). And, in ten out of the eleven farms, 
nineteen different types of multidrug resistant patterns were observed from the thirty nine e. 
coli that were isolated, as shown in Table 1. The resistant pattern was such that the e. coli was 
resistant to ciprofloxacin, norfloxacin, nalidicic acid (quinolones), penincillin, amoxyllin, 
cloxacillin (penincillin group of drugs), cefuroxine (2nd generation cephalosporin), 
gentamycin (Broad spectrum aminoglycoside), nitrofurantoin (nitrofurans), tetracycline, 
chloramphenicol, and cotrimoxazole (potentiated sulphonamide). The observation of 
resistance to the quinolones agrees with the earlier findings of e. coli to quinolones in 
many countries (GARAU et al., 1999; VIROY et al., 2005). The resistance to the penicillin 
group of drugs, tetracycline chloramphenicol, gentamycin may have been precipitated by 
the resistance to the quinolones (GARAU et al., 1999; KOMP et al., 2003). The consequences 
of these resistance patterns would be grave in terms of treatment of diseases in poultry 
and the possibility of transfer of drug resistance to humans.
Although the mechanism of spread of antibiotics resistance from food animals to 
humans, remains controversial, colonization of the intestinal tract with resistant e. coli 
from chicken has been shown in human volunteers and there is evidence that animals are 
a reservoir for e. coli found in humans (LINTON et al., 1977).
It is also known that resistant faecal e. coli from poultry can infect humans both 
directly and through food, by colonizing the human intestinal tract and contributing 
resistant genes to humans endogenous flora (VAN DEN BOGAARD et al., 2001). In Nigeria, 
ADETOSOYE (1980) reported multidrug resistant e. coli from humans and animals; one 
strain contained resistant factors for tetracycline, and two other strains contained resistant 
factors for ampicilin, chloramphenicol and compounds of sulphonamide.
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OjENIYI (1989) also described direct transmission of e. coli resistant to streptomycin, 
sulphonamide and tetracycline from poultry to poultry attendants. Elsewhere, chickens 
have also been described as a source of antibiotic resistance in humans (SINGH et al., 1992; 
AMARA et al., 1995; AL GHAMBI, 1999).
The findings from this work support the need for a critical review of the usage of 
antimicrobial agents in livestock in Nigeria and the importance of taking concrete steps in 
terms of policy to curtail the indiscriminate use of antimicrobial agents in a bid to prevent 
the possible adverse consequences in animal production, as well as in humans. There is an 
urgent need to formulate a policy and put the necessary plan in place to execute a policy 
targeted at the promotion of rational use of antimicrobial agents, as an important element 
in antimicrobial resistant containment. 
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SAŽETAK
Ukupno je 39 izolata bakterije escherichia coli bilo izdvojeno iz peradi sa septikemijom od listopada 
2005. do ožujka 2006. s 11 farmi u Abeokuti u jugozapadnoj Nigeriji. Svi su izolati bili pretraženi na osjetljivost 
prema antimikrobnim tvarima. e. coli bila je izdvojena iz 250 uzoraka tkiva različitih organa: crijeva, bubrega, 
pluća, srca, jajnika, slezene i izlaznoga crijeva (rektuma) oboljelih pilića dostavljenih na postmortalnu pretragu. 
Na osam od 11 pretraženih farmi bilo je rabljeno od tri do sedam različitih antimikrobnih tvari za liječenje, 
profilaksu ili pak kao promotori rasta. Ustanovljeno je da je 39 izolata e. coli pokazivalo 19 različitih načina 
višestruke otpornosti prema nitrofurantoinu (100 μg), cefuroksimu (20 μg), norfloksacinu (10 μg) kotrimoksazolu 
(50 μg), ciprofloksacinu (5 μg), nalidiksičnoj kiselini (30 μg), kloramfenikolu (10 μg), ampicilinu (10 μg, 25 
μg), ofloksacinu (5 μg), penicilinu G (5 i.j.), amoksicilinu (20 μg) i kloksacilinu (5 μg).
Ključne riječi: escherichia coli, mnogostruka otpornost, perad
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